Data for Prothena’s NEOD001 to be Presented at the 58th Annual American Society of Hematology Meeting
03 nov. 2016 09h20 HE
|
Prothena Corporation Plc
DUBLIN, Ireland, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization...
Prothena Reports Third Quarter 2016 Financial Results and Provides R&D Update
01 nov. 2016 16h05 HE
|
Prothena Corporation Plc
Net cash used in operating and investing activities was $39.1 million in the third quarter and $96.8 million for the first nine months of 2016; quarter-end cash and restricted cash position of...
Prothena to Report Third Quarter 2016 Financial Results on November 1
25 oct. 2016 16h05 HE
|
Prothena Corporation Plc
DUBLIN, Ireland, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization...
Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director
03 oct. 2016 07h00 HE
|
Prothena Corporation Plc
DUBLIN, Ireland, Oct. 03, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization...
In Memoriam – Friend, Scientific Innovator and Leader Dr. Dale B. Schenk has Passed Away
30 sept. 2016 14h45 HE
|
Prothena Corporation Plc
DUBLIN, Ireland, Sept. 30, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), announced today that its Co-founder, President and Chief Executive Officer, Dr. Dale B. Schenk, passed...
Prothena Outlines Phase 2 Development Strategy for PRX003
29 sept. 2016 16h05 HE
|
Prothena Corporation Plc
Investor conference call and webcast planned today at 4:30 PM ET DUBLIN, Ireland, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical...
Prothena Announces President and CEO Dr. Dale B. Schenk to Take Medical Leave
26 sept. 2016 16h05 HE
|
Prothena Corporation Plc
DUBLIN, Ireland, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization...
Prothena to Host Update on PRX003 Phase 2 Development Strategy
22 sept. 2016 16h05 HE
|
Prothena Corporation Plc
DUBLIN, Ireland, Sept. 22, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization...
Prothena Announces Appointment of Gene G. Kinney as Chief Operating Officer
06 sept. 2016 16h05 HE
|
Prothena Corporation Plc
DUBLIN, Ireland, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization...
Prothena to Participate in Upcoming September Investor Conferences
30 août 2016 16h05 HE
|
Prothena Corporation Plc
DUBLIN, Ireland, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of...